Development and validation of a life expectancy estimator for multimorbid older adults: a cohort study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
25 08 2021
Historique:
entrez: 26 8 2021
pubmed: 27 8 2021
medline: 15 9 2021
Statut: epublish

Résumé

Older multimorbid adults have a high risk of mortality and a short life expectancy (LE). Providing high-value care and avoiding care overuse, including of preventive care, is a serious challenge among multimorbid patients. While guidelines recommend to tailor preventive care according to the estimated LE, there is no tool to estimate LE in this specific population. Our objective is therefore to develop an LE estimator for older multimorbid adults by transforming a mortality prognostic index, which will be developed and internally validated in a prospective cohort. We will analyse data of the Optimising Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older People cohort study in Bern, Switzerland. 822 participants were included at hospitalisation with age of 70 years or older, multimorbidity (three or more chronic medical conditions) and polypharmacy (use of five drugs or more for Written informed consent by patients themselves or, in the case of cognitive impairment, by a legal representative, was required before enrolment. The local ethics committee (Kantonale Ethikkommission Bern) has approved the study. We plan to publish the results in peer-reviewed journals and present them at national and international conferences.

Sections du résumé

BACKGROUND
Older multimorbid adults have a high risk of mortality and a short life expectancy (LE). Providing high-value care and avoiding care overuse, including of preventive care, is a serious challenge among multimorbid patients. While guidelines recommend to tailor preventive care according to the estimated LE, there is no tool to estimate LE in this specific population. Our objective is therefore to develop an LE estimator for older multimorbid adults by transforming a mortality prognostic index, which will be developed and internally validated in a prospective cohort.
METHODS AND ANALYSIS
We will analyse data of the Optimising Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older People cohort study in Bern, Switzerland. 822 participants were included at hospitalisation with age of 70 years or older, multimorbidity (three or more chronic medical conditions) and polypharmacy (use of five drugs or more for
ETHICS AND DISSEMINATION
Written informed consent by patients themselves or, in the case of cognitive impairment, by a legal representative, was required before enrolment. The local ethics committee (Kantonale Ethikkommission Bern) has approved the study. We plan to publish the results in peer-reviewed journals and present them at national and international conferences.

Identifiants

pubmed: 34433596
pii: bmjopen-2020-048168
doi: 10.1136/bmjopen-2020-048168
pmc: PMC8388271
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e048168

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Trends Cardiovasc Med. 2015 Apr;25(3):228-39
pubmed: 25560975
Eur J Intern Med. 2016 Nov;35:35-42
pubmed: 27289492
BMJ. 2021 Jul 13;374:n1585
pubmed: 34257088
PLoS Med. 2013;10(2):e1001381
pubmed: 23393430
Heart. 2012 May;98(9):691-8
pubmed: 22397946
Stat Med. 2019 Mar 30;38(7):1276-1296
pubmed: 30357870
JAMA. 2012 Jan 11;307(2):182-92
pubmed: 22235089
Br J Gen Pract. 2018 Apr;68(669):e245-e251
pubmed: 29530918
Circulation. 2015 Jan 13;131(2):211-9
pubmed: 25561516
Ann Intern Med. 2014 Jul 15;161(2):104-12
pubmed: 25023249
BMJ. 2013 Jan 08;346:e8441
pubmed: 23299842
JAMA. 2006 Feb 15;295(7):801-8
pubmed: 16478903
BMJ Open. 2019 Jun 3;9(6):e026769
pubmed: 31164366
JAMA. 2013 Dec 25;310(24):2609-10
pubmed: 24322396
Heart. 2012 May;98(9):683-90
pubmed: 22397945
PLoS One. 2014 Sep 29;9(9):e108540
pubmed: 25265291
Circulation. 2007 Feb 20;115(7):928-35
pubmed: 17309939
J Clin Epidemiol. 2001 Jul;54(7):680-6
pubmed: 11438408
BMJ. 2020 Mar 18;368:m441
pubmed: 32188600

Auteurs

Viktoria Gastens (V)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland viktoria.gastens@biham.unibe.ch.
Graduate School for Health Sciences, University of Bern, Bern, Switzerland.

Cinzia Del Giovane (C)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland.

Daniela Anker (D)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland.

Martin Feller (M)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Lamprini Syrogiannouli (L)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.

Nathalie Schwab (N)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Douglas C Bauer (DC)

Departments of Medicine and Epidemiology & Biostatistics, University of California San Francisco, San Francisco, California, USA.

Nicolas Rodondi (N)

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Arnaud Chiolero (A)

Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland.
School of Global and Population Health, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH